Posttransplant cyclophosphamide-based graft-vs-host disease (GVHD) prophylaxis enabled high 1-year overall survival in patients receiving peripheral blood stem cell (PBSC) transplants from human ...

A high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.

HER3-DXd demonstrated activity in a phase 3 trial of patients with previously treated, EGFR-mutant NSCLC, but the BLA for HER3-DXd has been withdrawn.

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

Model includes age, body mass index, hypertriglyceridemia, tumor staging, tumor grade, CA125 level, platelet count, fibrinogen level.